What is the BlueInvest Project Pipeline?

See our showcase of innovative projects and entrepreneurs who are shaping the Blue Economy.

Projects consist of innovative, scalable and sustainable business ventures from traditional and emerging sectors of the maritime economy.

The graphs below provide an overview of the country distribution, sector, and TRL of projects currently listed in the BlueInvest Project Pipeline.

 

Submit your project

Selection Criteria:

Your company is EU-based or from an eligible sea basin region (Georgia, Turkey, Ukraine, Moldova, Montenegro, Albania, Bosnia-Herzegovina, North Macedonia, Serbia, Turkey, Israel, Egypt, Tunisia, Algeria, Morocco, Lebanon, Syria, Libya, Mauritania, United Kingdom, or Norway)

Your project TRL is 4 or higher

Your project sector is in one of the 10 blue economy sectors identified for this initiative

Your solution has a clear sustainable impact on the blue economy

Your project is looking for investment

Project Country

Country in which the project is being developed and / or implemented. 

Project Sector

Main blue economy sector the project relates to.

Project TRL

Current technology readiness level of the project. 

BLUE SKINCARE

The Power of Mother of Pearl: REPAIR & REGENERATE

  • Blue biotechnology

Company behind project
BLUE SKINCARE

France

About Us
Joel Drai is a renowned entrepreneur and founder of MEGA BIOPHARMA & BLUE SKINCARE.
In 1992, Joel Drai created and developed MEGA Dental, specializing in the distribution of dental and orthodontic supplies, which quickly became a leader with a 52% market share in the French domestic market, with over €160m in revenues. MEGA Dental has partnered with Henry SCHEIN, the world leader in dental.
Through the activity of MEGA Dental, Joel Drai met Drs Serge and Georges Camprasse, twin brothers from French Guadeloupe, and decided to invest in their research activities on a new biomaterial for the biomedical sector: mother-of-pearl.
From the beginning of the 1980s, they began research on various biomaterials. Then began decades of research (fundamental and applied) to understand the functioning of the oyster, the composition of mother-of-pearl, its structure, and its properties to make the most of it and maximize its potential medical applications.
The discoveries of Drs. Camprasse have aroused the medical community’s interest; they have also been the subject of many scientific publications. Their meeting with Joel Drai in 2009 is at the origin of the creation of MEGA BIOPHARMA, with the construction of their R&D lab near Le Mans where scores of POC on nacre efficacy have been tested successfully.

Since 2019, Didier Bensadoun, a finance industry expert (26 years as a Managing Director and CEO at Cantor Fitzgerald Capital Markets in New York, London, and Hong Kong) and a serial entrepreneur, joined forces to implement go-to-market strategies of innovative products generated by the company patented breakthrough technology.
Didier is an experienced President & CEO with a demonstrated history of working in finance & the internet industry. Strong business development professional skilled in Negotiation, Management, Trading, Structured Finance, and Hedge Funds.


The company has now 7 full-time employees and 4 external consultants.
For more than 25 years, the Drs. Camprasse have participated in more than 400 dental, orthopedic, and dermatological interventions. The company has also created an independent division, BLUE SKINCARE, dedicated to launching online and in pharmacies, a clean dermo-cosmetics brand in January 2023.




Problem we are solving
BLUE SKINCARE, A NEW DERMOCOSMETIC BRAND OFFFERING STRONG DIFFERENTIATION ASSETS FROM STATUTORY PHARMACY BRANDS
First and only reparative dermo-cosmetic brand that offers activated mother-of-pearl-based topical treatments and dietary supplements
New and exclusive patented proprietary mother-of-pearl based ingredients developed and manufactured in the GMP production facility of MEGA-BIOPHARMA, the parent company of BLUE SKINCARE
Our new promising ingredient for the skin. Its effectiveness has been proved by ex-vivo clinical studies
The only 100% clean dermo-cosmetics brand distributed in pharmacies. 100/100 Yuka scores for all BLUE SKINCARE products. Other statutory dermatological brands are mostly not clean
Desirable products, 100% Clean and Responsible with ecological-designed packaging and a reduced carbon footprint
First French clean dermo-cosmetics brand registered as “ENTREPRISE A MISSION”

Sustainable Impact on Blue Ecconomy
UPCYCLING OF SHELLS
Use of Pinctada Maxima oyster shells originally grown and harvested for the pearl industry (pearl trade)

A NON-THREATENED SPECIES
Does not appear in Annex 13 of the Washington Convention on International Trade
Breeding of the Pinctada Maxima in farms authorized by the regulations
Cultivation of the Pinctada Maxima is economically favourable to the countries that practice it
REDUCED CARBON FOOTPRINT
Over 75% of the selected ingredients are derived from France and Europe to reduce our carbon footprint

TRL
  • TRL 8 - Actual system completed through test and demonstration

  • Readiness Assistance Beneficiary


Financial NeedsBLUE SKINCARE has € 3-4 M financing needs for the next 3 years.

Planned Funding Allocation
  • Improve our R&D: 30%
  • Sales and Marketing: 30%
  • Operations: 15%
  • To hire more resources: 25%